Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dopergin

Known as: Dopergine, Schering Brand 2 of Lisuride Maleate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: hyperprolactinemia is a disorder which may be represented clinically by one or more of the following: galactorrhea… Expand
  • table 1
  • table 2
Is this relevant?
2013
2013
Lisuride Maleate (Dopergin) is semi synthetic ergot alkaloid used for a variety of medical conditions. It is licensed for use in… Expand
Is this relevant?
1998
1998
OBJECTIVES AND DESIGN The aim of study was evaluation of three methods of treatment of functional, evident hyperprolactinemia in… Expand
Is this relevant?
1995
1995
Lisuride (Dopergin, CAS 18016-80-3), a dopamine D2 agonist, was administered to male and female rats and mice continuously via… Expand
Is this relevant?
1991
1991
In order to evaluate a new dopaminergic prolactin inhibitor: lisuride hydrogen maleate (Dopergin R), in suppression of lactation… Expand
Is this relevant?
1990
1990
Thirteen women with hyperprolactinemic amenorrhea were treated with lisuride (Dopergin, Schering AG, Germany). The dosage of… Expand
Is this relevant?
1990
1990
Hyperprolactinemia can successfully be treated by dopaminagonists such as bromocriptin or lisuride. About 10% of patients… Expand
Is this relevant?
1989
1989
17 hyperprolactinemic and 2 acromegalic patients, aged 19-73, and 47 and 59 years, respectively, were treated with Lisuride… Expand
Is this relevant?
1986
1986
27 patients (12 women and 15 men) with hyperprolactinemia were treated with the dopamine agonists lisuride (Dopergin) and… Expand
Is this relevant?
1986
1986
The main medication is Madopar and Sinemet; various additives are able to reduce the Dopa dose in order to avoid various side… Expand
Is this relevant?